Hospital General Vall d'Hebron

Barcelona 08035

0 studies enrolling now · 9 studies all time

What they study most

Advanced Cancer, Breast Cancer, Fallopian Tube Cancer, Idiopathic Pulmonary Fibrosis, Melanoma and Metastatic Colorectal Cancer, Neoplasms, Ovarian Cancer, Peripheral T-cell Lymphoma, Peritoneal Neoplasms, Sarcoma

Studies at this site

• Male Breast Cancer: Understanding the Biology for Improved Patient Care — Running, not enrolling
• A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma — Completed
• Surgery With or Without Radiation Therapy in Untreated Nonmetastatic Retroperitoneal Sarcoma — Completed
• Pralatrexate vs Observation Following CHOP-based Chemotherapy in Undiagnosed Peripheral T-cell Lymphoma Patients — Stopped early
• Study of PF-05212384 (Also Known as PKI-587)Administered Intravenously To Subjects With Solid Tumors — Completed
• Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer — Stopped early
• OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer — Completed
• Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma — Stopped early
• Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study — Completed